Clinical Trials Directory

Trials / Completed

CompletedNCT04317235

Ultrasound-guided Interscalene Block:3mL Ropi Provide Similar Analgesia to 5mL and Less Diaphragmatic Paralysis

Ropivacaine for Ultrasound-guided Interscalene Block: 3mL Provide Similar Analgesia to 5mL With Less Diaphragmatic Paralysis in Shoulder Arthroscopy Surgeries

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
60 (actual)
Sponsor
Saint George Hospital · Academic / Other
Sex
All
Age
Healthy volunteers
Accepted

Summary

Ropivacaine for ultrasound-guided interscalene block: 3mL provide similar analgesia to 5mL with less diaphragmatic paralysis in shoulder arthroscopy surgeries

Detailed description

Ropivacaine for ultrasound-guided interscalene block: 3mL provide similar analgesia to 5mL with less diaphragmatic paralysis in shoulder arthroscopy surgeries with no toxicity and no adverse reaction or complications we targeted under echography each nerve to be blocked alone either to put around all the nerves a big volume

Conditions

Interventions

TypeNameDescription
DRUGRopivacaine 0.5% Injectable SolutionIs to put 3 ml or 5 ml and show the difference

Timeline

Start date
2016-01-10
Primary completion
2018-03-02
Completion
2019-01-20
First posted
2020-03-23
Last updated
2020-03-23

Source: ClinicalTrials.gov record NCT04317235. Inclusion in this directory is not an endorsement.